{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:44:09Z","timestamp":1762508649030},"reference-count":20,"publisher":"Medical Journals Sweden AB","issue":"11","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v101.352","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T11:41:33Z","timestamp":1634211693000},"page":"adv00593","source":"Crossref","is-referenced-by-count":1,"title":["Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis"],"prefix":"10.2340","volume":"101","author":[{"given":"Birgit","family":"Sadoghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birger","family":"Kr\u00e4nke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Cerroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Weger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"8325","doi-asserted-by":"crossref","unstructured":"Boehncke WH, Sch\u00f6n MP. Psoriasis. Lancet 2015; 386: 983-994.","DOI":"10.1016\/S0140-6736(14)61909-7"},{"key":"8326","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(14)61909-7","DOI":"10.1016\/S0140-6736(14)61909-7"},{"key":"8327","unstructured":"Nast A, Boehncke WH, Morwitz U, Ockenfels HM, Philipp S, Rosenbach T, et al. S3 guidelines for the treatment of psoriasis vulgaris. Update 2011. Available from: http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/013-001l_S3_Psoriasis_vulgaris_Therapie_01.pdf."},{"key":"8328","doi-asserted-by":"crossref","unstructured":"Sbidian E, Chaimani A, Afach S, Doney L, Dressler C, Hua C. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev 2021; 4: CD011535.","DOI":"10.1002\/14651858.CD011535.pub4"},{"key":"8329","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/14651858.CD011535.pub4","DOI":"10.1002\/14651858.CD011535.pub4"},{"key":"8330","doi-asserted-by":"crossref","unstructured":"Shiver MB, Hall AE, Conner KB, Brown GE, Cheung WL, Wirges ML. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity. Dermatol Online J 2014; 20: 13030.","DOI":"10.5070\/D3207023133"},{"key":"8331","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.5070\/D3207023133","DOI":"10.5070\/D3207023133"},{"key":"8332","doi-asserted-by":"crossref","unstructured":"Czarnecka-Operacz M, Sadowska-Przytocka A. The possibilities and principles of methotrexate treatment of psoriasis - the updated knowledge. Postepy Dermatol Allergol 2014; 31: 392-400.","DOI":"10.5114\/pdia.2014.47121"},{"key":"8333","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.5114\/pdia.2014.47121","DOI":"10.5114\/pdia.2014.47121"},{"key":"8334","doi-asserted-by":"crossref","unstructured":"Delyon J, Ortonne N, Benayoun E, Moroch J, Wolkenstein P, Sbidian E, et al. O. Low-dose methotrexate induced skin toxicity: keratinocyte dystrophy as a histologic marker. J Am Acad Dermatol 2015; 73: 484-490.","DOI":"10.1016\/j.jaad.2015.06.015"},{"key":"8335","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2015.06.015","DOI":"10.1016\/j.jaad.2015.06.015"},{"key":"8336","unstructured":"Zeltser R, Valle L, Tanck C, Holyst MM, Ritchlin, Gaspari AA. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein Arch Dermatol 2001; 137: 893-899."},{"key":"8337","unstructured":"Shear NH, Paul C, Blauvelt A Gooderham M, Leonardi C, Reich K, et al. Safety and tolerability of ixekizumab: integrated analysis of injection-site reactions from 11 clinical trials. J Drugs Dermatol 2018; 17: 200-206."},{"key":"8338","unstructured":"Corominas M, Gastaminza G, Lobera T. Hypersensitivity reactions to biological drugs. J Invest Allergol Clin Immunol 2014; 24: 212-225."},{"key":"8339","doi-asserted-by":"crossref","unstructured":"Benucci M, Manfredi M, Demoly P, Campi P. Injection site reactions to TNF alpha blocking agents with positive skin tests. Allergy 2008; 63: 138-139.","DOI":"10.1111\/j.1398-9995.2007.01536.x"},{"key":"8340","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1398-9995.2007.01536.x","DOI":"10.1111\/j.1398-9995.2007.01536.x"},{"key":"8341","doi-asserted-by":"crossref","unstructured":"Nakamizo S, Miyachi Y, Kabashima K. Addition of cyclosporine to adalimimab improved psoriasis and adalimumab. Induced injection site reaction. Indian J Dermatol 2014; 59: 522-523.","DOI":"10.4103\/0019-5154.139924"},{"key":"8342","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.4103\/0019-5154.139924","DOI":"10.4103\/0019-5154.139924"},{"key":"8343","doi-asserted-by":"crossref","unstructured":"\u00d6zkaya E. Fixed drug eruption: state of the art. J Dtsch Dermatol Ges 2008; 6: 181-188.","DOI":"10.1111\/j.1610-0387.2007.06491.x"},{"key":"8344","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1610-0387.2007.06491.x","DOI":"10.1111\/j.1610-0387.2007.06491.x"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/352\/980","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/352\/981","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/352\/980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T09:20:32Z","timestamp":1675761632000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.2340\/actadv.v101.352","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,16]]}}}